Add BrightSurf on Google Email

Medical College of Georgia at Augusta University


MCG neuroscientist receives $2.3 million in funding from NIH High-Risk, High-Reward Research program

Danielle Mor, a neuroscientist at the Medical College of Georgia, has been awarded $2.3 million to study the progression of Parkinson's disease through the use of C. elegans and innovative research approaches. Her goal is to understand how misfolded proteins spread from the gastrointestinal tract to the central nervous system.

MCG scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Researchers investigated the connection between androgen deprivation therapy for prostate cancer and Alzheimer's disease. They found that ADT can exacerbate cognitive decline by increasing brain immune cell infiltration, but a combination with Natalizumab improved integrity of the blood-brain barrier and reduced inflammation.

$2.4 million grant helping MCG scientists better understand what happens to our skeleton as we age

Researchers are studying the role of stress hormones and mineralocorticoid receptors in bone health as we age. The goal is to understand how balance between these factors affects our skeletons. By investigating this complex relationship, scientists hope to develop new insights into osteoporosis and other age-related bone disorders.

MCG scientists identify new treatment target for leading cause of blindness

Researchers at MCG's Vascular Biology Center have identified a new treatment target for age-related macular degeneration (AMD), a leading cause of blindness. Targeting the adenosine receptor 2A (Adora2a) may block excessive blood vessel growth and fibrosis, potentially offering a more efficient treatment than current therapies.

SourceMedical College of Georgia at Augusta University·JournalScience Translational Medicine·DateMay 2, 2024

Synthetic peptide could reduce vascular problems associated with COVID-ARDS

Researchers have developed a synthetic peptide that could help reduce vascular problems associated with acute respiratory distress syndrome in COVID-19. The peptide, called TIP, works by binding to a subunit of the epithelial sodium channel, which helps maintain barrier function and prevent damage from viral proteins.

SourceMedical College of Georgia at Augusta University·JournalFrontiers in Immunology·DateOct 3, 2023

Augusta University researcher calls for modernizing the UN's traditional approach to population replacement measurement

Augusta University researcher Arni S.R. Srinivasa Rao calls for updating the UN's traditional approach to measuring population replacement levels. He proposes a new formula that allows for more timely and accurate measurement, which is essential for understanding emerging global demographics.

SourceMedical College of Georgia at Augusta University·JournalMathematical Biosciences·DateAug 25, 2023

The antipsychotic clozapine linked to significantly less insomnia in people with schizophrenia

A new meta-analysis found that clozapine is associated with decreased insomnia and a lower risk of suicide in patients with schizophrenia. The study suggests that clozapine's ability to improve sleep quality may be linked to its reduced suicide risk, and highlights the importance of assessing and treating insomnia in these patients.

SourceMedical College of Georgia at Augusta University·JournalSchizophrenia Research·DateApr 26, 2023

Cancer that spreads to the lung maneuvers to avoid being attacked by “killer” T cells

Cancer cells have been found to employ a strategy to evade the immune system's killer T cells by interacting with myeloid cells and suppressing type 1 interferon production. This natural pathway is crucial for recruiting killer T cells to combat cancer spread. Researchers hope to develop new therapeutic approaches, such as forcing tumo...

Richard McIndoe, PhD, will direct Coordinating Unit for new, national research initiative in diabetes, obesity

Richard McIndoe is leading a national research initiative to advance understanding of diabetes and obesity through the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD). The MPMOD initiative provides access to advanced testing services, including bariatric surgery on mice, to enable new insights ...

Gene essential to making DNA appears to be a good target in minimizing pulmonary hypertension

Researchers discover that inhibiting a gene crucial for DNA production can significantly reduce destructive cell proliferation and disease progression in pulmonary hypertension. This finding presents a potential treatment target for the condition, which affects females aged 30-60 with limited treatment options.

SourceMedical College of Georgia at Augusta University·JournalEuropean Heart Journal·DateMar 14, 2023

Vibrating capsule doubles the ability for constipation sufferers to poop without drugs

A vibrating capsule designed to stimulate the colon has been shown to double the number of complete spontaneous bowel movements in adults with debilitating chronic constipation. The device, which is not a drug and works directly in the colon, showed significant improvement in symptoms such as straining and stool consistency.

When chronic stress activates these neurons, behavioral problems like loss of pleasure, depression result

Scientists found that chronic stress increases the activity of proopiomelanocortin (POMC) neurons, leading to behaviors such as anhedonia and depression. Inhibiting POMC neuron activity reduced these behavioral changes. The study suggests that POMC neurons play a key role in increasing susceptibility to stress-related behavioral problems.

SourceMedical College of Georgia at Augusta University·JournalMolecular Psychiatry·DateJan 24, 2023

Optimal genome mapping offers high-resolution method to better see, then target cancer-causing gene variants

A new study standardizes the use of optical genome mapping (OGM) for patients with blood cancers, demonstrating its potential as a frontline test for diagnosing hematologic malignancies. OGM outperforms existing tests in detecting cancer-causing gene variants and identifying additional information that can improve patient outcomes.

SourceMedical College of Georgia at Augusta University·JournalJournal of Molecular Diagnostics·DateJan 17, 2023

Antibodies to common antibiotic possible new risk factor for type 1 diabetes

A study found that antibodies to common antibiotic gentamicin are associated with an increased risk of progression to type 1 diabetes in children already genetically at risk. The researchers also identified an association between the FUT2 gene and the production of these antibodies, which may be compounding risks for type 1 diabetes.

SourceMedical College of Georgia at Augusta University·JournalNature Communications·DateDec 8, 2022

Common, usually harmless group of bacteria associated with higher death rates in kidney patients

Researchers found a significant association between NTM infection and increased mortality in patients with end-stage renal disease. Early diagnosis and treatment may improve survival. NTM can cause nonspecific symptoms like fever and weight loss, and patients with compromised immune systems are at higher risk.

SourceMedical College of Georgia at Augusta University·JournalJournal of Investigative Medicine·DateOct 25, 2022

Powerful enzyme that tamps down inflammation holds promise for protecting the eyes in diabetes, premature birth

Researchers found that increasing arginase 1 availability helps alleviate unhealthy responses and interrupt destructive inflammation in diabetic retinopathy and retinopathy of prematurity. This is achieved by reducing L-arginine levels, which in turn reduces inducible nitric oxide synthase activity.

SourceMedical College of Georgia at Augusta University·JournalCell Death and Disease·DateOct 12, 2022

Scientists chase down what motor proteins deliver to healthy cells to find what’s altered in neurological diseases

Researchers investigate how motor proteins transport vital proteins and RNAs to the right location within cells, where they can cause or prevent genetic neurological diseases. By understanding these highly regulated transport systems, scientists hope to develop new treatments for conditions like spinal muscular atrophy and Charcot-Mari...

As few as 1 in 5 COVID cases may have been counted worldwide, mathematical models suggest

Mathematical models suggest that only 1 in 5 COVID-19 cases were counted worldwide, resulting in an estimated 600 million to 2.4 billion actual cases globally. The wide range of estimated cases highlights the problems with accuracy of reported numbers due to data tampering, inconsistent reporting, and lack of uniformity.

Molecular changes in the brain in the aftermath of a traumatic event may help explain long-term susceptibility or resilience

Researchers found that stressed mice exhibited decreased neuron excitability in the dorsal hippocampus, which may drive social avoidance, while resilient mice showed increased excitability. This difference was linked to changes in stress hormone receptors and HCN1 protein expression.

SourceMedical College of Georgia at Augusta University·JournalMolecular Psychiatry·DateSep 20, 2022

New labeling approach enables examination of packages cells send out to gain insight about health

Researchers have developed a new labeling technique to analyze exosomes from specific cell types, providing insights into their role in both health and disease. The technique allows for the identification of protein cargo and RNA in exosomes, enabling the study of cellular communication and potential monitoring of response to treatment.

SourceMedical College of Georgia at Augusta University·JournalJournal of Extracellular Vesicles·DateAug 30, 2022

Peptide delivered by nasal spray can reduce seizure activity, protect neurons in Alzheimer’s, epilepsy

Researchers developed a peptide that can be administered through nasal spray to reduce seizure activity and protect neurons in both Alzheimer's and epilepsy. The A1R-CT peptide inhibits neurabin, a protein that prevents the overactivation of neurons, allowing for increased action by adenosine receptors.